D-0012-2024 Class II Terminated
FDA drug recall D-0012-2024 was initiated by Central Admixture Pharmacy Services Inc on September 21, 2023 and is designated Class II. Reason for recall: Lack of assurance of sterility: The recall status is terminated (terminated March 19, 2025). Affected quantity: 5,378 100 mL bags.
Recall Details
- Product Type
- Drugs
- Report Date
- October 11, 2023
- Initiation Date
- September 21, 2023
- Termination Date
- March 19, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 5,378 100 mL bags
Product Description
fentaNYL in 0.9% sodium chloride, 1,000 mcg/100 mL, (10 mcg/mL), 100 mL bag, Rx only, CAPS, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-2071-4
Reason for Recall
Lack of assurance of sterility:
Distribution Pattern
Nationwide in the USA
Code Information
Lot: 17-275314, 17-275319, 17-275320, 17-275324, 17-275327, 17-275328, 17-275349, Exp. 10/3/2023; 17-275510, 17-275531, 17-275536, 17-275541, 17-275548, Exp. 10/5/2023; 17-275656, Exp. 10/8/2023; 17-275714, Exp. 10/9/2023; 17-275766, 17-275786, 17-275787, 17-275802, Exp. 10/10/2023; 17-275918, 17-275926, Exp. 10/12/2023; 17-275951, Exp. 10/13/2023; 17-275966, 17-275975, 17-275977, Exp. 10/15/2023; 17-276103, Exp 10/17/2023.